What Researchers Did
Researchers described a single patient whose jaw bone damage, caused by medication, was successfully treated with hyperbaric oxygen therapy.
What They Found
In this case report, a patient suffering from medication-related osteonecrosis of the jaw (MRONJ) showed successful treatment with hyperbaric oxygen therapy (HOT). The therapy led to an improvement in the patient's quality of life and a reduction in the severity of their condition.
What This Means for Canadian Patients
For Canadian patients experiencing medication-related osteonecrosis of the jaw (MRONJ), this case suggests that hyperbaric oxygen therapy (HBOT) could be a beneficial treatment option. While more research is needed, this report offers a positive example of HBOT improving patient outcomes for this challenging condition.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a case report, this study's findings are limited to a single patient and may not be generalizable to all individuals with medication-related osteonecrosis of the jaw.